Multiple Sclerosis

Multiple Sclerosis (MS) is an inflammatory disease of unknown origin that affects the central nervous system. It is the most common disease causing disability among young people. About 3,500 Saskatchewan people are living with MS.

For information about symptoms, diagnosis, treatment and medications and support services, see Related Links below.

MS RESEARCH

Saskatchewan was the first jurisdiction in Canada to commit funding for clinical trials of the Multiple Sclerosis Liberation Therapy, pioneered by Italian surgeon Dr. Paolo Zamboni as a treatment for Chronic Cerebrospinal Venous Insufficiency (CCSVI).

The province is partnering with a research group conducting a Liberation Therapy clinical trial in Albany, New York.

Applications are now closed for MS patients from Saskatchewan
who want to apply to participate in the clinical trial.